OLIVER LAGORE VANVALIN INVESTMENT GROUP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
OLIVER LAGORE VANVALIN INVESTMENT GROUP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,758
+14.1%
97
+7.8%
0.01%
+25.0%
Q2 2023$10,307
-16.9%
900.0%0.00%
-20.0%
Q1 2023$12,405
+6.4%
900.0%0.01%
-28.6%
Q4 2022$11,662
+16.6%
900.0%0.01%
+16.7%
Q3 2022$10,000
+42.9%
900.0%0.01%
+50.0%
Q2 2022$7,0000.0%900.0%0.00%
-20.0%
Q1 2022$7,000900.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,999,453$413,414,60713.31%
Casdin Capital, LLC 1,160,000$159,882,80013.17%
Ikarian Capital, LLC 271,300$37,393,2798.48%
Avoro Capital Advisors LLC 3,650,000$503,079,5007.46%
Evolutionary Tree Capital Management, LLC 36,190$4,988,0686.91%
Finepoint Capital LP 122,757$16,919,5976.46%
Ikarian Capital, LLC 205,400$28,310,2826.42%
Boxer Capital, LLC 775,000$106,8185.25%
Ghost Tree Capital, LLC 125,000$17,229,0005.09%
Logos Global Management LP 220,000$30,322,6004.34%
View complete list of SAREPTA THERAPEUTICS INC shareholders